KR950005828A - 다중-약물 내성을 조절하기 위한 삼치환된 피리미도 [5, 4-d] 피리미딘, 이들 화합물을 함유하는 약제학적 조성물 및 이들 화합물의 제조방법 - Google Patents
다중-약물 내성을 조절하기 위한 삼치환된 피리미도 [5, 4-d] 피리미딘, 이들 화합물을 함유하는 약제학적 조성물 및 이들 화합물의 제조방법 Download PDFInfo
- Publication number
- KR950005828A KR950005828A KR1019940018961A KR19940018961A KR950005828A KR 950005828 A KR950005828 A KR 950005828A KR 1019940018961 A KR1019940018961 A KR 1019940018961A KR 19940018961 A KR19940018961 A KR 19940018961A KR 950005828 A KR950005828 A KR 950005828A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- substituted
- amino
- piperidino
- alkyl
- Prior art date
Links
- JOZPEVMCAKXSEY-UHFFFAOYSA-N pyrimido[5,4-d]pyrimidine Chemical class N1=CN=CC2=NC=NC=C21 JOZPEVMCAKXSEY-UHFFFAOYSA-N 0.000 title claims abstract 5
- 238000000034 method Methods 0.000 title claims abstract 3
- 150000001875 compounds Chemical class 0.000 title claims 20
- 239000008194 pharmaceutical composition Substances 0.000 title claims 5
- 230000036457 multidrug resistance Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract 11
- 206010028980 Neoplasm Diseases 0.000 claims abstract 2
- -1 pyrrolidino, piperidino Chemical group 0.000 claims 35
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 11
- 125000004432 carbon atom Chemical group C* 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 7
- 239000000460 chlorine Chemical group 0.000 claims 7
- 229910052801 chlorine Inorganic materials 0.000 claims 7
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 7
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 6
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 6
- 239000011737 fluorine Substances 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 6
- 125000003282 alkyl amino group Chemical group 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 4
- 125000001246 bromo group Chemical group Br* 0.000 claims 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 3
- 125000001153 fluoro group Chemical group F* 0.000 claims 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 2
- 125000005236 alkanoylamino group Chemical group 0.000 claims 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000005505 thiomorpholino group Chemical group 0.000 claims 2
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims 1
- YIWSBONCEROBAF-UHFFFAOYSA-N 1-[8-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]-n,n-dimethylpiperidin-4-amine Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(C1=N2)=NC=NC1=C(N1CCOCC1)N=C2N1CCC(N(C)C)CC1 YIWSBONCEROBAF-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 1
- 230000009435 amidation Effects 0.000 claims 1
- 238000007112 amidation reaction Methods 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 150000001728 carbonyl compounds Chemical class 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000006842 cycloalkyleneimino group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 1
- IDDKWUHMCKWAEE-UHFFFAOYSA-N methyl n-[1-[8-[benzyl(methyl)amino]-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]piperidin-4-yl]carbamate Chemical compound C1CC(NC(=O)OC)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2N(C)CC=3C=CC=CC=3)C2=N1 IDDKWUHMCKWAEE-UHFFFAOYSA-N 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- KXCXDESVYWWYMK-UHFFFAOYSA-N n-benzyl-2-[4-(dimethylamino)piperidin-1-yl]-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CC(N(C)C)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2N(C)CC=3C=CC=CC=3)C2=N1 KXCXDESVYWWYMK-UHFFFAOYSA-N 0.000 claims 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 claims 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 238000006722 reduction reaction Methods 0.000 claims 1
- 238000006268 reductive amination reaction Methods 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000001235 sensitizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4325900A DE4325900A1 (de) | 1993-08-02 | 1993-08-02 | Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DEP4325900.6 | 1993-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950005828A true KR950005828A (ko) | 1995-03-20 |
Family
ID=6494272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940018961A KR950005828A (ko) | 1993-08-02 | 1994-08-01 | 다중-약물 내성을 조절하기 위한 삼치환된 피리미도 [5, 4-d] 피리미딘, 이들 화합물을 함유하는 약제학적 조성물 및 이들 화합물의 제조방법 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5618814A (sv) |
| EP (1) | EP0645390A1 (sv) |
| JP (1) | JPH0789963A (sv) |
| KR (1) | KR950005828A (sv) |
| CN (1) | CN1041091C (sv) |
| AU (1) | AU683888B2 (sv) |
| BG (1) | BG98931A (sv) |
| CA (1) | CA2129179A1 (sv) |
| CZ (1) | CZ184594A3 (sv) |
| DE (1) | DE4325900A1 (sv) |
| EE (1) | EE9400255A (sv) |
| FI (1) | FI943574A (sv) |
| HU (1) | HUT70957A (sv) |
| IL (1) | IL110509A (sv) |
| NO (1) | NO301479B1 (sv) |
| NZ (1) | NZ264133A (sv) |
| PL (1) | PL304512A1 (sv) |
| RO (1) | RO113557B1 (sv) |
| RU (1) | RU94028278A (sv) |
| SK (1) | SK91594A3 (sv) |
| TW (1) | TW251286B (sv) |
| ZA (1) | ZA945689B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW414798B (en) * | 1994-09-07 | 2000-12-11 | Thomae Gmbh Dr K | Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| DE19608653A1 (de) * | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| USRE37234E1 (en) * | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
| US7618975B2 (en) * | 2003-07-03 | 2009-11-17 | Myriad Pharmaceuticals, Inc. | 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| US8309562B2 (en) * | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| DE102004002557A1 (de) * | 2004-01-17 | 2005-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen |
| US8258145B2 (en) * | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| CN115650827B (zh) * | 2022-10-27 | 2024-03-15 | 戊言医药科技（上海）有限公司 | 用于一类蒽环类毒素衍生物的制备方法、中间体化合物及合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3069211D1 (en) * | 1979-07-03 | 1984-10-25 | Thomae Gmbh Dr K | 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them |
| DE2931573A1 (de) * | 1979-08-03 | 1981-02-26 | Thomae Gmbh Dr K | Mittel zur bekaempfung des wachstums von krebszellen und dessen herstellung |
| DE3049207A1 (de) * | 1980-12-27 | 1982-07-29 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel |
| DE3423092A1 (de) * | 1984-06-22 | 1986-01-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| DE3833392A1 (de) * | 1988-10-01 | 1990-04-05 | Thomae Gmbh Dr K | Verwendung von pyrimido(5,4-d)pyrimidinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel |
-
1993
- 1993-08-02 DE DE4325900A patent/DE4325900A1/de not_active Withdrawn
-
1994
- 1994-07-07 TW TW083106205A patent/TW251286B/zh active
- 1994-07-26 EP EP94111739A patent/EP0645390A1/de not_active Withdrawn
- 1994-07-27 RO RO94-01270A patent/RO113557B1/ro unknown
- 1994-07-28 BG BG98931A patent/BG98931A/bg unknown
- 1994-07-29 NZ NZ264133A patent/NZ264133A/en unknown
- 1994-07-29 SK SK915-94A patent/SK91594A3/sk unknown
- 1994-07-29 IL IL110509A patent/IL110509A/en not_active IP Right Cessation
- 1994-07-29 CA CA002129179A patent/CA2129179A1/en not_active Abandoned
- 1994-08-01 ZA ZA945689A patent/ZA945689B/xx unknown
- 1994-08-01 NO NO942853A patent/NO301479B1/no unknown
- 1994-08-01 KR KR1019940018961A patent/KR950005828A/ko not_active Application Discontinuation
- 1994-08-01 AU AU68813/94A patent/AU683888B2/en not_active Ceased
- 1994-08-01 CN CN94114910A patent/CN1041091C/zh not_active Expired - Fee Related
- 1994-08-01 PL PL94304512A patent/PL304512A1/xx unknown
- 1994-08-01 FI FI943574A patent/FI943574A/sv unknown
- 1994-08-01 HU HU9402253A patent/HUT70957A/hu unknown
- 1994-08-01 JP JP6179359A patent/JPH0789963A/ja active Pending
- 1994-08-01 RU RU94028278/04A patent/RU94028278A/ru unknown
- 1994-08-02 CZ CZ941845A patent/CZ184594A3/cs unknown
- 1994-08-02 US US08/284,325 patent/US5618814A/en not_active Expired - Fee Related
- 1994-11-23 EE EE9400255A patent/EE9400255A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO942853D0 (sv) | 1994-08-01 |
| FI943574A0 (sv) | 1994-08-01 |
| NZ264133A (en) | 1996-05-28 |
| AU6881394A (en) | 1995-02-09 |
| CA2129179A1 (en) | 1995-02-03 |
| FI943574A (sv) | 1995-02-03 |
| NO942853L (no) | 1995-02-03 |
| RO113557B1 (ro) | 1998-08-28 |
| SK91594A3 (en) | 1995-04-12 |
| IL110509A0 (en) | 1994-10-21 |
| IL110509A (en) | 1998-01-04 |
| AU683888B2 (en) | 1997-11-27 |
| NO301479B1 (no) | 1997-11-03 |
| ZA945689B (en) | 1996-02-01 |
| DE4325900A1 (de) | 1995-02-09 |
| PL304512A1 (en) | 1995-02-06 |
| US5618814A (en) | 1997-04-08 |
| EP0645390A1 (de) | 1995-03-29 |
| EE9400255A (et) | 1996-02-15 |
| TW251286B (sv) | 1995-07-11 |
| HU9402253D0 (en) | 1994-09-28 |
| RU94028278A (ru) | 1996-08-27 |
| CZ184594A3 (en) | 1995-02-15 |
| CN1106405A (zh) | 1995-08-09 |
| BG98931A (en) | 1995-09-29 |
| HUT70957A (en) | 1995-11-28 |
| JPH0789963A (ja) | 1995-04-04 |
| CN1041091C (zh) | 1998-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950005828A (ko) | 다중-약물 내성을 조절하기 위한 삼치환된 피리미도 [5, 4-d] 피리미딘, 이들 화합물을 함유하는 약제학적 조성물 및 이들 화합물의 제조방법 | |
| AR035349A1 (es) | Compuestos de pirimidinona, composiciones farmaceuticas que los comprenden, uso de tales compuestos en la fabricacion de medicamentos y proceso para la preparacion de dichos compuestos | |
| AU4954793A (en) | New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds | |
| WO1998009953A3 (de) | Azinyloxy- und phenoxy-diaryl-carbonsäure derivate, deren herstellung und deren verwendung als gemischte eta/etb endothelin-rezeptorantagonist | |
| AU2012250517A1 (en) | Compounds for inhibiting cell proliferation in EGFR-driven cancers | |
| AU2001272476A1 (en) | Piperidines for use as orexin receptor antagonists | |
| ATE206420T1 (de) | Methylenoxindolderivate und verfahren zu ihrer herstellung | |
| MY100124A (en) | Dihydropyridazinones. | |
| AU7741994A (en) | Aminoquinoline derivatives | |
| CA2128493A1 (en) | Aminobenzoic acid derivatives | |
| KR920019746A (ko) | 신규한 시클로헥실벤즈아미드 유도체, 그의 제조방법 및 약제로서의 용도 | |
| AU7616387A (en) | Novel aminoalkylthio derivatives of triazolopyridine or triazoloquinoline, the processes for their preparation, and drugs, useful especially as analgesics, in which they are present | |
| NZ220306A (en) | 4(5)-(substituted-1h-inden-2-yl)-imidazoles and pharmaceutical compositions | |
| HUT51257A (en) | Process for producing 1-/1h-imidazol-4-yl/-benzamide derivatives and pharmaceutical compositions comprising same | |
| HK1115728A1 (en) | Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
| WO1999062893A3 (de) | Neue neurokininantagonisten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| KR910006231A (ko) | 치환된 알킬 피레리딘 및 콜레스테롤 합성 억제제로서 이의 용도 | |
| KR840004731A (ko) | 2,4-디아미노-5-(치환된)피리미딘의 제조방법 | |
| HUP0000854A2 (hu) | 4-[6-Fluor-(1H)-indol-3-il]-1,2,3,6-tetrahidropiridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás mindezek előállítására | |
| EP0884318A4 (en) | CONDENSED PURINE DERIVATIVES | |
| HUP9900739A2 (hu) | Eljárás kinolinszármazékok előállítására és intermedierjeik | |
| KR960007560A (ko) | 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도 | |
| ES8104248A1 (es) | Procedimiento de preparacion de 6-amino-sustituidas-3-piri- dazinilhidrazinas y de sus sales de adicion acidas terapeu- ticamente aceptables | |
| HUP0000315A2 (hu) | Heterociklusos szubsztituált pirrolidin-amid származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| IE852384L (en) | Pyridyl-piperidyl compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |